Browsing: Mortality Risk

Two areas of research are providing the gerontology community with the most promise: dysregulated nutrient sensing and cell senescence.

Since the COVID-19 pandemic, a striking divergence has emerged in the UK. While pensioners are living longer, working-age adults are facing worsening mortality rates.

The global equity release/reverse mortgage market could be worth $56bn by 2035, according to a new report from EY and industry group the European Pensions and Property Asset Release Group.

People with mental health conditions often suffer from worse physical health, have more age-related diseases, and have a lower average life expectancy than people without a mental illness.

At the end of June, the Continuous Mortality Investigation in the UK, which produces mortality data and analysis, issued its latest update, CMI_2024, which showed an increase in cohort life expectancies at age 65 in England and Wales.

The report, which covers the period 2024/2025, analyses data received from market leaders across 13 countries internationally across Europe, North America and Australia with established or developing equity release markets and explores their growth potential.

General mortality trend in England continues downwards but certain diseases getting worse.

Advances in early detection and treatment have significantly improved survival outcomes, especially in non-metastatic cases. However, prognosis varies greatly depending on the stage at diagnosis, molecular characteristics, and the extent of metastasis.

Life Risk News Q&A: Matthew Sheridan of Health Data Analytics Institute to get his thoughts on how predictive modelling is helping US health systems to better triage patients and model risk.

In a rare bright spot for the product, growth was observed in the 61+ age cohort.